New combination of anti-MADCAM antibody and antifibrotic caspase inhibitor to treat liver fibrosis
A protease inhibitor and anti-fibrosis technology, applied in the direction of antibodies, anti-inflammatory agents, drug combinations, etc., can solve problems such as unmet medical needs
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0077] The combined anti-fibrotic agent of the present invention is preferably a protease inhibitor, more preferably a caspase inhibitor, further preferably a compound of formula I, or a pharmaceutically acceptable salt thereof
[0078]
[0079] Formula I
[0080] in,
[0081] A is a natural or unnatural amino acid of formula IIa-i:
[0082]
[0083] B is hydrogen atom, deuterium atom, alkyl, cycloalkyl, phenyl, substituted phenyl, naphthyl, substituted naphthyl, 2-benzoxazolyl, substituted 2-oxazolyl, (CH 2 ) n -Cycloalkyl, (CH 2 ) n -Phenyl, (CH 2 ) n -(substituted phenyl), (CH 2 ) n -(1 or 2-naphthyl), (CH 2 ) n -(substituted 1 or 2-naphthyl), (CH 2 ) n -(heteroaryl), (CH 2 ) n -(substituted heteroaryl), halomethyl, CO 2 R 12 、CONR 13 R 14 、CH 2 ZR 15 、CH 2 OCO (aryl), CH 2 OCO (heteroaryl) or CH 2 OPO(R 16 )R 17 , wherein Z is an oxygen or sulfur atom, or B is a group of formula IIIa-c:
[0084]
[0085] R 1 is al...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 